BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26765580)

  • 1. Serum PTHrP Predicts Weight Loss in Cancer Patients Independent of Hypercalcemia, Inflammation, and Tumor Burden.
    Hong N; Yoon HJ; Lee YH; Kim HR; Lee BW; Rhee Y; Kang ES; Cha BS; Lee HC
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1207-14. PubMed ID: 26765580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer.
    Lee JY; Hong N; Kim HR; Lee BW; Kang ES; Cha BS; Lee YH
    Endocrinol Metab (Seoul); 2018 Mar; 33(1):97-104. PubMed ID: 29589391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models.
    Fujimoto-Ouchi K; Onuma E; Shirane M; Mori K; Tanaka Y
    Cancer Chemother Pharmacol; 2007 May; 59(6):807-15. PubMed ID: 17009035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
    Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma.
    Deans C; Wigmore S; Paterson-Brown S; Black J; Ross J; Fearon KC
    Cancer; 2005 May; 103(9):1810-8. PubMed ID: 15800880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone-related peptide and survival of patients with cancer and hypercalcemia.
    Truong NU; deB Edwardes MD; Papavasiliou V; Goltzman D; Kremer R
    Am J Med; 2003 Aug; 115(2):115-21. PubMed ID: 12893397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia].
    Blind E; Raue F; Meinel T; Pecherstorfer M; Räth U; Schmidt-Gayk H; Kohl B; Ziegler R
    Dtsch Med Wochenschr; 1993 Mar; 118(10):330-5. PubMed ID: 8453901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
    Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
    J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer.
    Grill V; Ho P; Body JJ; Johanson N; Lee SC; Kukreja SC; Moseley JM; Martin TJ
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1309-15. PubMed ID: 1955513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis.
    Martin L; Muscaritoli M; Bourdel-Marchasson I; Kubrak C; Laird B; Gagnon B; Chasen M; Gioulbasanis I; Wallengren O; Voss AC; Goldwasser F; Jagoe RT; Deans C; Bozzetti F; Strasser F; Thoresen L; Kazemi S; Baracos V; Senesse P
    J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1189-1202. PubMed ID: 34448539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients.
    Pecherstorfer M; Schilling T; Blind E; Zimmer-Roth I; Baumgartner G; Ziegler R; Raue F
    J Clin Endocrinol Metab; 1994 May; 78(5):1268-70. PubMed ID: 8175989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of anti-parathyroid hormone-related protein monoclonal antibody and osteoprotegerin on PTHrP-producing tumor-induced cachexia in nude mice.
    Iguchi H; Aramaki Y; Maruta S; Takiguchi S
    J Bone Miner Metab; 2006; 24(1):16-9. PubMed ID: 16369893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the BMI-adjusted weight loss grading system and quality of life in patients with incurable cancer.
    Daly L; Dolan R; Power D; Ní Bhuachalla É; Sim W; Fallon M; Cushen S; Simmons C; McMillan DC; Laird BJ; Ryan A
    J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):160-168. PubMed ID: 31692296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTHrP-mediated hypercalcemia: causes and survival in 138 patients.
    Donovan PJ; Achong N; Griffin K; Galligan J; Pretorius CJ; McLeod DS
    J Clin Endocrinol Metab; 2015 May; 100(5):2024-9. PubMed ID: 25719931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma.
    Horiuchi T; Miyachi T; Arai T; Nakamura T; Mori M; Ito H
    Horm Metab Res; 1997 Sep; 29(9):469-71. PubMed ID: 9370119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight loss and resting energy expenditure in male patients with newly diagnosed esophageal cancer.
    Wu J; Huang C; Xiao H; Tang Q; Cai W
    Nutrition; 2013; 29(11-12):1310-4. PubMed ID: 24012284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating PTHrP concentrations in tumor-induced hypercalcemia: influence on the response to bisphosphonate and changes after therapy.
    Body JJ; Dumon JC; Thirion M; Cleeren A
    J Bone Miner Res; 1993 Jun; 8(6):701-6. PubMed ID: 8328312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
    Burtis WJ; Brady TG; Orloff JJ; Ersbak JB; Warrell RP; Olson BR; Wu TL; Mitnick ME; Broadus AE; Stewart AF
    N Engl J Med; 1990 Apr; 322(16):1106-12. PubMed ID: 2320080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone-related protein (PTHrP) as a causative factor of cancer-associated wasting: possible involvement of PTHrP in the repression of locomotor activity in rats bearing human tumor xenografts.
    Onuma E; Tsunenari T; Saito H; Sato K; Yamada-Okabe H; Ogata E
    Int J Cancer; 2005 Sep; 116(3):471-8. PubMed ID: 15800941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced hypercalcemia and parathyroid hormone-related protein in lung carcinoma.
    Takai E; Yano T; Iguchi H; Fukuyama Y; Yokoyama H; Asoh H; Ichinose Y
    Cancer; 1996 Oct; 78(7):1384-7. PubMed ID: 8839542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.